These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 18927521

  • 1. Certolizumab (Cimzia) for Crohn's disease.
    Med Lett Drugs Ther; 2008 Oct 20; 50(1297):81-2. PubMed ID: 18927521
    [No Abstract] [Full Text] [Related]

  • 2. FDA approves Cimzia to treat Crohn's disease.
    Lang L.
    Gastroenterology; 2008 Jun 20; 134(7):1819. PubMed ID: 18474249
    [No Abstract] [Full Text] [Related]

  • 3. [Certolizumab pegol--new possibilities in the treatment of Crohn's disease].
    Lazebnik LB, Kniazev OV.
    Eksp Klin Gastroenterol; 2012 Jun 20; (3):100-5. PubMed ID: 22830233
    [No Abstract] [Full Text] [Related]

  • 4. Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.
    Augustine JM, Lee JK, Armstrong EP.
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct 20; 14(5):599-609. PubMed ID: 25209304
    [Abstract] [Full Text] [Related]

  • 5. The classics in perspective.
    Panés J, Ghosh S.
    Gut; 2007 Sep 20; 56(9):1184-6. PubMed ID: 17698863
    [No Abstract] [Full Text] [Related]

  • 6. How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
    Krygier DS, Ko HH, Bressler B.
    Expert Rev Gastroenterol Hepatol; 2009 Aug 20; 3(4):407-15. PubMed ID: 19673627
    [Abstract] [Full Text] [Related]

  • 7. Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ, PRECISE 2 Study Investigators.
    N Engl J Med; 2007 Jul 19; 357(3):239-50. PubMed ID: 17634459
    [Abstract] [Full Text] [Related]

  • 8. Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease.
    Smith LS, Nelson M, Dolder CR.
    Ann Pharmacother; 2010 Feb 19; 44(2):333-42. PubMed ID: 20118143
    [Abstract] [Full Text] [Related]

  • 9. Certolizumab pegol for the treatment of Crohn's disease.
    Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S, PRECISE 1 Study Investigators.
    N Engl J Med; 2007 Jul 19; 357(3):228-38. PubMed ID: 17634458
    [Abstract] [Full Text] [Related]

  • 10. Certolizumab pegol for the management of Crohn's disease in adults.
    Rivkin A.
    Clin Ther; 2009 Jun 19; 31(6):1158-76. PubMed ID: 19695385
    [Abstract] [Full Text] [Related]

  • 11. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors.
    Prescrire Int; 2009 Jun 19; 18(101):108-10. PubMed ID: 19637418
    [Abstract] [Full Text] [Related]

  • 12. Certolizumab pegol (Cimzia) and ustekinumab (Stelara) for psoriatic arthritis.
    Med Lett Drugs Ther; 2014 Feb 03; 56(1435):10-2. PubMed ID: 24662976
    [No Abstract] [Full Text] [Related]

  • 13. Drug approvals: '08 in review. Certolizumab pegol (Cimzia).
    Laustsen G, Carrillo F, Johnson J, Smith C.
    Nurse Pract; 2009 Feb 03; 34(2):26-7. PubMed ID: 19155878
    [No Abstract] [Full Text] [Related]

  • 14. Anti TNF-alpha treatment for Crohn' disease: "ménage a trois".
    Danese S.
    Curr Drug Targets; 2010 Feb 03; 11(2):136-7. PubMed ID: 20214597
    [No Abstract] [Full Text] [Related]

  • 15. TNF inhibitors for Crohn's disease: when, which, and for how long.
    Med Lett Drugs Ther; 2013 Dec 23; 55(1432):102-3. PubMed ID: 24419244
    [No Abstract] [Full Text] [Related]

  • 16. Certolizumab pegol.
    Melmed GY, Targan SR, Yasothan U, Hanicq D, Kirkpatrick P.
    Nat Rev Drug Discov; 2008 Aug 23; 7(8):641-2. PubMed ID: 18670430
    [Abstract] [Full Text] [Related]

  • 17. [Certolizumab Pegol targets inflammatory processes].
    Krankenpfl J; 2005 Aug 23; 43(7-10):231. PubMed ID: 16515300
    [No Abstract] [Full Text] [Related]

  • 18. The safety of biologic agents in the treatment of inflammatory bowel disease.
    Shepela C.
    Minn Med; 2008 Jun 23; 91(6):42-5. PubMed ID: 18616021
    [Abstract] [Full Text] [Related]

  • 19. [Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn disease. A survey of a Cochrane review].
    Al-Subeihe I, Nielsen OH.
    Ugeskr Laeger; 2008 Dec 08; 170(50):4130-4. PubMed ID: 19091193
    [No Abstract] [Full Text] [Related]

  • 20. Certolizumab pegol: in Crohn's disease.
    Blick SK, Curran MP.
    BioDrugs; 2007 Dec 08; 21(3):195-201; discussion 202-3. PubMed ID: 17516714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.